Question 1

Why does pulmonary hypertension cause right ventricular failure rather than left ventricular failure initially?

Dr. Biswarup Purkayastha · Accepted Answer

The right ventricle is a volume-handling ventricle, not designed for pressure overload — you can load it with considerable volume and it won't fail, because volume is its domain. But impose a pressure overload, as in pulmonary hypertension, and it hypertrophies to compensate before eventually failing. The left ventricle is a pressure-handling ventricle, built for exactly that load. That's why pulmonary hypertension causes right heart failure long before it affects the left.

Question 2

What is the mechanism of pulmonary hypertension in HIV?

Dr. Biswarup Purkayastha · Accepted Answer

Two mechanisms operate together. Viral proteins cause stiffness in the lung's interstitial tissue, which physically compresses the pulmonary blood vessels. At the same time, the immunocompromised state associated with HIV promotes smooth muscle hyperplasia within the vessel walls, narrowing the lumen from within. It's the combination of external compression and internal luminal narrowing that drives HIV-associated pulmonary hypertension.

Question 3

Why is P2 loud in pulmonary hypertension?

Dr. Biswarup Purkayastha · Accepted Answer

The pulmonary valve opens against a high-pressure circuit, so when it closes, it's slammed shut by that elevated pressure — a forceful, rapid closure that produces the loud P2. It isn't the size of the valve that determines the loudness, it's the closing pressure. That's why even in conditions like tetralogy of Fallot, where pulmonary stenosis would normally produce a soft P2, elevated pulmonary arterial pressure from collateral flow can still produce a loud P2 despite the outflow obstruction.

Question 4

What antihypertensives are safe in pregnancy?

Dr. Biswarup Purkayastha · Accepted Answer

After the first trimester, amlodipine and other calcium channel blockers are reasonably safe. For eclampsia or hypertension specifically during pregnancy, the preferred agent is a direct alpha agonist, such as prazosin.

Question 5

What is the PVR threshold for starting medical therapy in pulmonary hypertension?

Dr. Biswarup Purkayastha · Accepted Answer

Any mean pulmonary artery pressure greater than 20 mmHg combined with a pulmonary vascular resistance greater than 2 Wood units should be started on therapy — at minimum, a PDE5 inhibitor plus an endothelin receptor antagonist as double therapy. If the patient remains symptomatic, we add a prostacyclin analog to complete triple therapy. Escalating beyond triple therapy to sotatercept should only be considered after at least six months to a year of adequate triple therapy without sufficient response.

Question 6

What are the three major pharmacological pathways in pulmonary hypertension treatment?

Dr. Biswarup Purkayastha · Accepted Answer

First, PDE5 inhibition, to promote vascular relaxation via the cGMP pathway. Second, soluble guanylate cyclase stimulation, to address back-pressure and encourage vasodilation. Third, endothelin receptor blockade, to retard smooth muscle cell hypertrophy and reduce pulmonary vascular resistance. Sotatercept adds a fourth, distinct pathway — anti-proliferative inhibition of activin signalling — which addresses the underlying vascular remodelling rather than just haemodynamics.

Pulmonary Hypertension - A Multidisciplinary Approach

Questions Doctors Asked Dr. Biswarup Purkayastha